Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Artemether MeSH Descriptor Data 2025


MeSH Heading
Artemether
Tree Number(s)
D01.339.431.125.250
D02.389.593.187.250
D02.455.849.765.211.250
Unique ID
D000077549
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077549
Scope Note
An artemisinin derivative that is used in the treatment of MALARIA.
Entry Term(s)
Artemether, (3R-(3alpha,5abeta,6alpha,8abeta,9alpha,10beta,12beta,12aR*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8aalpha,9alpha,10beta,12beta,12aR*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer
Artenam
O-Methyldihydroartemisinine
alpha-Artemether
beta-Arthemeter
Pharm Action
Antimalarials
Registry Numbers
C7D6T3H22J
0
76496-28-1
80286-56-2
111W6L37CC
Related Numbers
111W6L37CC
71939-51-0
71963-77-4
76496-28-1
80286-56-2
CAS Type 1 Name
3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-
Public MeSH Note
2019; ARTEMETHER was indexed under ARTEMISININS 2006-2018; under SESQUITERPENES 1981-2005; and under PYRANS 1982-1988
History Note
2019 (1982)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2023/03/20
Artemether Preferred
Artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer Narrower
Artemether, (3R-(3alpha,5abeta,6alpha,8abeta,9alpha,10beta,12beta,12aR*))-isomer Narrower
Artemether, (3R-(3alpha,5abeta,6beta,8aalpha,9alpha,10beta,12beta,12aR*))-isomer Narrower
Artenam Narrower
beta-Arthemeter Narrower
alpha-Artemether Narrower
page delivered in 0.143s